Literature DB >> 12721494

Historical perspective of the renin-angiotensin system.

John E Hall1.   

Abstract

Researchers continue to be fascinated with the renin-angiotensin system (RAS) more than 100 yr after its discovery because of its powerful role in controlling sodium balance, body fluid volumes, and arterial pressure. Development of drugs that block different components of this system has led to powerful treatments for hypertension, heart failure, diabetes, and other diseases. Molecular approaches to studying this system offer new possibilities for better understanding the physiology and pathophysiology of the RAS, and for developing new therapeutic paradigms. Our challenge in the future will be to effectively utilize the technological advances that are taking place in virtually all areas of science, including the RAS, and to translate them into a better understanding of the pathophysiology and treatment of human diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721494     DOI: 10.1385/MB:24:1:27

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  46 in total

1.  PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

Authors:  R P AMES; A J BORKOWSKI; A M SICINSKI; J H LARAGH
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

2.  Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man.

Authors:  J H LARAGH; M ANGERS; W G KELLY; S LIEBERMAN
Journal:  JAMA       Date:  1960-09-17       Impact factor: 56.272

3.  Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

Authors:  M A Ondetti; N J Williams; E F Sabo; J Pluscec; E R Weaver; O Kocy
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.

Authors:  H R Brunner; H Gavras; J H Laragh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

6.  Quantitative analysis of the pathophysiology of hypertension.

Authors:  A C Guyton; T G Coleman
Journal:  Circ Res       Date:  1969-05       Impact factor: 17.367

7.  Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.

Authors:  Y S Bakhle
Journal:  Nature       Date:  1968-11-30       Impact factor: 49.962

8.  Radioimmunoassay determination of plasma-renin activity.

Authors:  G W Boyd; A E Fitz; A R Adamson; W S Peart
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

9.  Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules.

Authors:  V L Schuster; J P Kokko; H R Jacobson
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

10.  Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats.

Authors:  H Gavras; H B Brunner; E D Vaughan; J H Laragh
Journal:  Science       Date:  1973-06-29       Impact factor: 47.728

View more
  25 in total

Review 1.  Evolution, kidney development, and chronic kidney disease.

Authors:  Robert L Chevalier
Journal:  Semin Cell Dev Biol       Date:  2018-06-05       Impact factor: 7.727

Review 2.  Interorgan Communication Pathways in Physiology: Focus on Drosophila.

Authors:  Ilia A Droujinine; Norbert Perrimon
Journal:  Annu Rev Genet       Date:  2016-10-10       Impact factor: 16.830

Review 3.  Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.

Authors:  Terry K W Ma; Kevin K H Kam; Bryan P Yan; Yat-Yin Lam
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Generation and characterization of a novel kidney-specific manganese superoxide dismutase knockout mouse.

Authors:  Nirmala Parajuli; Akira Marine; Sloane Simmons; Hamida Saba; Tanecia Mitchell; Takahiko Shimizu; Takuji Shirasawa; Lee Ann Macmillan-Crow
Journal:  Free Radic Biol Med       Date:  2011-04-17       Impact factor: 7.376

5.  A-type K+ channels contribute to the prorenin increase of firing activity in hypothalamic vasopressin neurosecretory neurons.

Authors:  Soledad Pitra; Javier E Stern
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

6.  Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Authors:  Toshihide Kashihara; Tsutomu Nakada; Katsuhiko Kojima; Toshikazu Takeshita; Mitsuhiko Yamada
Journal:  J Physiol       Date:  2017-04-20       Impact factor: 5.182

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

Review 8.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

9.  Stunting growth: association of the blood pressure levels and ACE activity in early childhood.

Authors:  Andréia Febba; Ricardo Sesso; Gênia Pithon Barreto; Claudia Silva Liboni; Maria C P Franco; Dulce Elena Casarini
Journal:  Pediatr Nephrol       Date:  2008-09-13       Impact factor: 3.714

10.  Cytomegalovirus infection causes an increase of arterial blood pressure.

Authors:  Jilin Cheng; Qingen Ke; Zhuang Jin; Haibin Wang; Olivier Kocher; James P Morgan; Jielin Zhang; Clyde S Crumpacker
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.